Get in touch

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Group - A smiling older man with a gray beard sits while a woman stands behind him, hugging him. Text reads, "LAUNCH OF BUPRENORPHINE IN SOUTH AFRICA." The TIEFENBACHER PHARMACEUTICALS logo is at the top, highlighting expertise in generic medicines manufacturing.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Tiefenbacher Group about affordable medicines

Tiefenbacher Group - A pharmacist in a white coat smiles behind a counter. Infographics display bar charts on the European affordable medicines market, highlighting economic value, supply chain, access, and innovation by a family-owned pharmaceutical company.

Why are affordable medicines so important for healthcare?Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. […]

Tiefenbacher Pharmaceuticals Launch: Varenicline in UK

Tiefenbacher Group - A woman in a blue knit hat and winter coat stands outdoors with eyes closed. Text reads, "Launch of Varenicline in the United Kingdom." The TIEFENBACHER Pharmaceuticals logo, a family-owned pharmaceutical company, appears at the top left.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of Varenicline in the UnitedKingdom! WHO has added Varenicline to the […]

Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine

Tiefenbacher Group - An older couple dressed in winter gear stands smiling on a snowy mountain with trekking poles. The Tiefenbacher Pharmaceuticals logo highlights the launch of Amifampridine across Europe by this family-owned pharmaceutical company.

Tiefenbacher Pharmaceuticals Successfully Prepares the Launch of Amifampridine Across Europe At Tiefenbacher Pharmaceuticals, we are deeply committed to making high-quality, life-changing medications affordable and accessible to patients worldwide, regardless of, nationality, or income. That’s why we are excited to share that we have successfully prepared the launch of Amifampridine Tablets 10mg. This is the first generic […]

Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin

Tiefenbacher Group - Smiling older man outdoors, wearing a blue vest and carrying a backpack. Text: "Launch of Ezetimibe / Atorvastatin in European Union." Family-owned pharmaceutical company focused on patient-centric drug development. TIEFENBACHER PHARMACEUTICALS logo at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared […]

Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe

Tiefenbacher Group - A young woman stands outdoors with her eyes closed and hands on her chest, appearing calm and content. Text reads: "Launch of Varenicline across European Union." Tiefenbacher Pharmaceuticals, a family-owned pharmaceutical company, logo is at the top.

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the only available Varenicline containing product in Europe. WHO has […]

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Group - An older smiling couple embraces outdoors. The image features the logo "Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, and a banner reading "Launch of the analgesic buprenorphine in Australia.

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled […]

TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES

Tiefenbacher Group - A young girl wearing glasses and a white lab coat smiles and points upward, standing next to the text "Tiefenbacher Medical Devices," representing innovative pharmaceutical healthcare solutions on a light background.

Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device business into a new stand-alone company: TIEFENBACHER MEDICAL DEVICES. The launch follows TIEFENBACHER GROUP´s strategy to offer better patient therapies by combining established drug-based medicines with medical devices and digital […]

Get in touch